FMO5 and pulmonary arterial hypertension: The above findings are supported by a study showing that hypoxia-induced ET-1 promotes SMC proliferation via NADPH oxidase activation, contributing to pulmonary hypertension induced by hypoxia exposure (Wu et al., 2007).